Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Harefuah|April 24, 2012
[Mast cell proliferation and activation in disease processes]Alon Hershko, Yoseph Mekori
Harefuah|November 12, 2009
[The broken heart syndrome]Leor Perl, Leor Perel, Yoseph Mekori, et al.
Israel Journal of Health Policy Research|July 31, 2014
The role of medical schools in promoting social accountability through shared decision-makingOrit Karnieli-Miller, Yaara Zisman-Ilani, Dafna Meitar, et al.
Harefuah|October 21, 2015
[EXCELLENCE IN QUALITY, SERVICE AND RESEARCH]Alon Hershko, Mira Maram Edri, Eytan Wirtheim
Harefuah|April 17, 2003
[Retroperitoneal fibrosis--clinical response to steroid treatment]Hila Elinav, Alon Hershko, Gil Leibovitch, et al.
BMJ Case Reports|September 28, 2022
Recurrent haemoptysis: a rare diagnosis of kaposiform lymphangiomatosis and review of literatureRoukhama Fedidat, Anna Elia, Alon Hershko, et al.
European Journal of Case Reports in Internal Medicine|July 13, 2022
A Transient Inflammatory Reaction with a B-Cell Lymphoid Infiltrate and Dysplastic Bone Marrow Changes Associated with the BNT162b2 COVID-19 VaccineDaniella Vronsky, Shimrit Hershkowitz, Alon Hershko, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 22, 2022
Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine)Yaelle Bavli, Bing-Mae Chen, Guy Gross, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2017
Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin HypersensitivityRonit Confino-Cohen, Yossi Rosman, Keren Meir-Shafrir, et al.
The Journal of Allergy and Clinical Immunology. Global|June 11, 2025
First-in-class intranasal epinephrine spray for anaphylaxis: Dose finding clinical studyTair Lapidot, Yuval Tal, Dalia Megiddo, et al.
Pageof 2